The University of Freiburg (colloquially German: Uni Freiburg), officially the Albert Ludwig University of Freiburg (German: Albert-Ludwigs-Universität Freiburg), is a public research university located in Freiburg im Breisgau, Baden-Württemberg, Germany.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
Metastases are largely responsible for the death rate of patients with solid cancers; the prognosis of cancer patients reduces significantly if metastases are diagnosed. Until now there has been no procedure available to ...
Mar 4, 2024
0
35
When the eye jumps from one point to another, the image of our surroundings rapidly passes across the retina and triggers a wave of neuronal activity. In order not to be overwhelmed by the sensory impressions produced by ...
Nov 30, 2023
0
52
CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy ...
Nov 6, 2023
0
22
Researchers at the Faculty of Medicine at the University of Freiburg have gained significant new insights into metabolic processes in the kidney. The scientists from the Institute of Genetic Epidemiology at the Medical Center—University ...
Jun 5, 2023
0
51
An interdisciplinary research team at the University of Freiburg has found important clues about the functioning of the sensorimotor cortex. The new findings on neuronal activities in this brain area could be helpful for ...
Dec 5, 2022
0
125
The omicron variant of SARS-CoV-2 has caused another major wave of infection worldwide. This is because even vaccinated individuals or those who had contracted a previous variant of the virus can become infected with omicron. ...
May 2, 2022
0
107
What gets into the brain and what doesn't is strictly regulated. Researchers at the Faculty of Medicine at the University of Freiburg have now studied phagocytes that coat the blood vessels in the brain and reinforce the ...
Apr 22, 2022
0
165
Around 50,000 people suffer sudden cardiac arrest in Germany every year. When occurring outside a hospital, the chances of survival are only ten percent. Survivors often suffer from severe permanent neurological damage. On ...
Jul 22, 2021
0
143
Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...
Feb 10, 2021
0
141
Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent immunological memory and thus can protect against a new infection. Several studies had shown that SARS-CoV-2 specific antibodies ...
Nov 17, 2020
0
519
